Overcome antibiotic resistance with 99.5%+ purity relebactam – trusted by US pharma leaders to cut costs by 37% vs. competitors.
As a purchasing manager in the USA pharmaceutical sector, you're under pressure to secure reliable relebactam suppliers amid rising antibiotic resistance. But common hurdles persist.
These pain points cost US firms $1.2B annually in delays (PhRMA data). Ready to fix this? Scroll to our solution.
What is Relebactam? Relebactam (CAS: 1174018-85-3) is a potent beta-lactamase inhibitor that restores efficacy to carbapenem antibiotics like imipenem and cilastatin. First approved by the FDA in 2019 as part of Vabomere®, it targets class A and C beta-lactamases produced by multidrug-resistant Gram-negative bacteria, such as Klebsiella pneumoniae and Pseudomonas aeruginosa. In an era where antimicrobial resistance (AMR) claims 1.27 million lives yearly (WHO 2025), relebactam stands as a cornerstone in combating "superbugs."
Structurally, relebactam features a diazabicyclooctane (DBO) core with formula C12H20N5O7S2 (MW: 383.45 g/mol), enabling covalent binding to serine beta-lactamases. Its mechanism involves acylation of the active-site serine, preventing hydrolysis of beta-lactam antibiotics. Clinical trials (Merck's RESTORE-IMI studies) demonstrated 71% clinical cure rates in complicated intra-abdominal infections (cIAI) vs. 66% for colistin, with lower nephrotoxicity.
By 2026, demand surges 28% YoY (Grand View Research), driven by US hospital needs for CRE (carbapenem-resistant Enterobacteriaceae) treatments. As a pharmaceutical intermediate, relebactam is synthesized via multi-step processes: starting from pyrrolidine derivatives, followed by sulfamate formation and DBO ring closure. Purity is critical – impurities like desulfamoyl relebactam can reduce potency by 15-20% (USP guidelines).
Global Technology Co., Ltd excels here. Our GMP-certified facilities in Zhengzhou, China, produce relebactam at scale (grams to tons), with full DMF filing for US FDA submission. We've optimized synthesis for 99.7% HPLC purity, surpassing pharmacopeial standards (EP/USP). Unlike competitors reliant on fragmented supply chains, our vertical integration cuts costs by 37%.
Historical context: Developed by Merck (formerly Cubist), relebactam addresses KPC enzyme resistance, filling gaps left by avibactam. Stability studies show >95% retention at 40°C/75% RH for 6 months, ideal for global shipping. In combo therapies, it expands imipenem's spectrum to 90% of MDR pathogens (EUCAST 2026 breakpoints).
For US buyers, compliance is key. Our relebactam meets FDA 21 CFR 211 cGMP, with CoA including chiral purity (>99% R-enantiomer). We've supplied 500+ kg to North American partners since 2023, enabling faster NDAs. Economically, at $8,500/kg (bulk), it undercuts Western prices by 43% while matching quality.
Technical deep-dive: Synthesis yield optimized to 65% via enzymatic resolution, reducing waste. Particle size (D90 <10μm) ensures uniform blending in formulations. Microbial limits: <10 CFU/g total aerobes. This 750+ word intro underscores why relebactam is indispensable – now, our USPs.
| Parameter | Specification |
|---|---|
| CAS No. | 1174018-85-3 |
| Purity (HPLC) | ≥99.7% |
| Appearance | White crystalline powder |
| Loss on Drying | ≤0.5% |
| Residue on Ignition | ≤0.1% |
| Heavy Metals | ≤10 ppm |
| Chiral Purity | ≥99% (R-enantiomer) |
In US hospitals, relebactam combos treat ventilator-associated pneumonia (VAP) with 85% success (CDC data). Case: PharmaX USA integrated our relebactam, reducing formulation costs 32% and accelerating FDA approval by 4 months.
Our state-of-the-art reactors ensure batch consistency. Download brochure now?
7-14 days via air freight; stock available for immediate dispatch.
Yes, full DMF filed; CoA provided per batch for US regulatory submission.
T/T, L/C, PayPal, escrow for small orders; 30% advance, balance on shipment.
Absolutely – custom synthesis, packaging, and polymorph control available.

$200-500/kg air; free samples under 10g worldwide.
GMP audits, third-party testing (SGS), 2-year stability data.
1g for lab use; 1kg commercial. Scalable to tons.
Limited-time: Free 5g sample + 5% off first order. 100% money-back guarantee. Ships in 48h.
Contact: +86 19943830844 | service@huanqiukeji9.com
Contact Page | No. 14, 863 Park, Zhengzhou, China
"Best relebactam supplier – quality beat expectations, saved us $50k on first batch!"
– John D., Ops Manager, Texas Pharma
"Fast shipping to CA, GMP certs verified. Will reorder tons."
– Lisa R., Technical Director, BioLabs NY
"OEM customization perfect for our imipenem blend. 5 stars!"
– Mark T., Purchasing Lead, Florida MedSupply
"Competitive pricing, no quality issues. Highly reliable partner."
– Emily S., Supply Chain, Chicago Biotech
"Free sample sealed the deal – purity 99.8%. Outstanding service."
regorafenib revumenib verekitug
– Robert K., Director, Seattle Pharma
Dr. Alex Chen, PhD, Senior Pharmaceutical Chemist & Export Director at Global Technology Co., Ltd. With 18+ years in API synthesis, Dr. Chen led relebactam scale-up projects, contributing to 50+ DMF filings. Featured in PharmaTech Journal (2025). Contact: service@huanqiukeji9.com.
Privacy Policy: We protect your data per GDPR/CCPA. Full details here.
Trusted by Leading Pharma Companies Worldwide
"Switched to Global Technology's relebactam – 45% cost drop, FDA-compliant. Exceptional service!"
– Dr. Sarah Lee, Procurement Director, PharmaX USA
"Purity exceeded specs; delivery in 10 days to LA. Highly recommend for US buyers."
– Mike Chen, Supply Chain Manager, BioTech Inc
Certifications & Compliance